Analysis reports flare occurrences in rheumatoid arthritis patients, indicating predictors and management implications.
Flares occurred in approximately 14% of RA patients during b/tsDMARD treatment, with baseline joint involvement, particularly shoulder swelling, being a predictor. While the adjustment of csDMARDs was associated with reduced steroid use during flare management, it did not significantly affect b/tsDMARD retention rates.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: